The standard set
The ICHOM Standard Set for Adults who live with type 1 and 2 Diabetes is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to persons with Diabetes. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
1 Evaluated via WHO-5
2 Evaluated via PAID
3 Evaluated via PHQ-9
Download the flyer
A brief overview of the most important outcomes for patients relating to this ICHOM Standard Set.
Reference Guide
A complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors.
Data Dictionary
An index of the outcomes and case-mix variables included in the standard set, how to code them, and the information you need to collect when implementing the outcomes in practice.
Team that developed this standard
Project team
Chair | Fabrizio Carinci | University of Bologna
Chair | Massimo Massi-Benedetti | Hub for International Health Research
Research Fellow | Jana Nano | Erasmus MC/ Institute of Epidemiology/Helmholtz Zentrum München, German Research Center for Environmental Health/German Center for Diabetes Research (DZD)
Research Fellow | Magdalena Walbaum | Catholic University of Chile/Ministry of Health, Chile
Project Leader | Oluwakemi Okunade | ICHOM
Research Associate | Sarah Whittaker | ICHOM
Australia
Tim Benson* | WHO Patients for Patient Safety/ Consumers Health Forum of Australia/ Health Consumers Council of Western Australia
Rob Haig*
Belize
Sharon Fraser | International Diabetes Federation
Cameroon
Jean Claude Mbanya | University of Yaounde I
Canada
Maria Santana | O’Brien Institute for Public Health
Denmark
Søren Eik Skovlund | Aalborg University and Aalborg University Hospital
Germany
Andreas Schmitt | Diabetes Center Mergentheim
India
Anil Bhansali | Postgraduate Institute of Medical Education and Research
Israel
Ronit Calderon-Margalit | The Hebrew University of Jerusalem
Malaysia
Mark Prabhaharan*
Mexico
Cristina García Ulloa | Instituto Nacional de Ciencia Médicas y Nutrición
Sergio Hernández Jiménez | Instituto Nacional de Ciencia Médicas y Nutrición
Portugal
João Raposo | APDP/Nova Medical School Lisbon
Singapore
Hwee-Lin Wee | Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science, National University of Singapore
Slovenia
Jana Klavs | University Medical Centre Ljubljana Slovenia
Jelka Zaletel | National Institute of Public Health Slovenia/University Medical Centre Ljubljana Slovenia
South Africa
Naomi Levitt | University of Cape Town
Switzerland
Daniel Barthelmes | University Hospital Zurich
United Arab Emirates
Jihan Dennaoui | National Health Insurance Company - Daman
Saf Naqvi | Imperial College London Diabetes Centre
United Kingdom
Katharine Barnard | Bournemouth University
Paul Buchanan* | GBDOC/ Blue Circle Voices¹
United States
Anne Peters | The Keck School of Medicine of the University of Southern California
Mark Peyrot | Loyola University Maryland
William Polonsky | Behavioral Diabetes Institute, University of California
Andrew Pumerantz | Western Diabetes Institute, Western University of Health Sciences
*Patient representative
¹affiliated until August 2017
Stay up to date
To receive updates about new versions and opportunities to implement this standard set, please submit your details below
View more standard sets
Diabetes
Diabetes, blood, and endocrine
Paediatric Facial Palsy
Congenital anomalies
Congenital Upper Limb Anomalies
Congenital anomalies
Inflammatory Arthritis
Musculoskeletal
